ArticleHeliyon2024
Timing is essential: Humoral and cellular responses to SARS-CoV-2 vaccination in a cohort of patients with auto-immune diseases treated with rituximab.
Irène Gallais Sérézal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.